Join us online at COVERGENCE OCT 22-23
The University Tech/Startup Gap Fund and Accelerator Summit
- 20 in-depth gap fund/accelerator program reviews
- Breakout and group discussions on common challenges
- Corporate and Investor partnering panels
- Networking web-site and associated materials
The university is one of only six institutions in the UK to be awarded with a BHF Accelerator Award, which encourages pioneering research of the highest calibre. It will bolster the university’s research in atrial fibrillation (AF), heart failure, thrombo-inflammation and vascular biology.
Advancing research from bench to bedside
The award will create a joined-up research pipeline from discovery science to health services research, including the provision of integrated training for scientists and clinical academics.
Researchers will also have greater access to super-resolution imaging, complex disease models, clinical research infrastructure and large datasets – all of which will help advance their research from bench to bedside.
The award will further fund a number of new positions that will help to integrate research excellence, including new research nurse capacity in local hospitals, data scientists working within the Midlands Health Data Research UK (HDR-UK) and fundamental researchers embedded into the Institute of Cardiovascular Sciences and the Centre of Membrane Proteins and Receptors (COMPARE).
Develop new treatments
Award director Professor Paulus Kirchhof said: “This award recognises that we have a strong cohort of emerging leaders and upcoming researchers, whose work will be supported by this vital funding.
“This investment will greatly accelerate translation of new scientific discoveries to develop new treatments for patients in the city and beyond.”
Professor Sir Nilesh Samani, our Medical Director, added: “The BHF Accelerator Award is recognition of the quality of the cardiovascular research at the University of Birmingham.
“We currently fund around £13 million of research at the university, and the flexible funding provided by the Accelerator Award will enable researchers to develop novel ideas more rapidly, promote inter-disciplinary research and support the careers of early stage researchers.
“We are very pleased to have made this award, which is only possible through the generosity of the public who support us.”
In the West Midlands region alone, there are around 670,000 people living with the daily burden of heart and circulatory diseases – with these conditions claiming more than 15,300 lives per year.